Chemed Corp. Aktie
Chemed Corp. Aktie
Was spricht für und gegen Chemed Corp. in den nächsten Jahren?
Pro
Kontra
Rendite von Chemed Corp. im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Chemed Corp. | -0,93 % | - | - | - | - | - | - |
Amn Healthcare Svs | - | 1,80 % | 7,62 % | -35,06 % | -15,67 % | -22,07 % | 26,90 % |
Ensign Group Inc. | 0,00 % | 0,92 % | 0,00 % | - | 6,80 % | - | - |
Select Medical Holdings | 0,63 % | 5,23 % | - | - | - | - | - |
Kommentare
News
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2024
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities Health Care Conference 2024 on Tuesday, May 14, 2024, at 1:40 PM (PDT) at the
Chemed Reports First-Quarter 2024 Results
Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest
VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama
VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation (“Chemed”) (NYSE: CHE) announced the completion of the previously announced purchase of all hospice operations and an